When we talk about rheumatoid arthritis (RA), we often think about painful, swollen joints. But RA is more than a joint disease—it’s an inflammatory condition that affects the entire body. One of the most serious concerns for people with RA is the increased risk of cardiovascular disease, including high blood pressure, heart attacks, and strokes.

Recently, a study published in the Annals of Medicine explored the connection between RA, methotrexate treatment, and cardiovascular risk factors. Researchers found that RA patients treated with methotrexate showed lower blood pressure compared to those not on the medication.

Why Does This Matter?

High blood pressure is one of the most significant risk factors for heart disease. Since RA patients already have higher rates of cardiovascular events, this finding is especially meaningful.

It’s important to note that methotrexate itself is not a blood pressure medication. Instead, the benefits come from reducing overall inflammation in the body. When inflammation improves, blood pressure may improve as well.

Inflammation and Metabolic Health: A Two-Way Street

This study highlights a fascinating link between immune health and metabolic health. On one hand, controlling inflammation in RA not only helps the joints but also lowers the risk of cardiovascular disease. On the other hand, poor metabolic health—such as high blood sugar, elevated cholesterol, or obesity—can worsen inflammation.

This means the relationship is bidirectional:

• Less inflammation = better heart health

• Better metabolic health = less inflammation

Practical Steps for Patients with RA

If you are living with RA or another chronic autoimmune condition, here are ways to improve both joint health and cardiovascular health:

• Focus on nutrition: A diet rich in whole foods, lean proteins, vegetables, and anti-inflammatory fats can lower both inflammation and cardiovascular risk.

• Exercise regularly: Physical activity helps control blood sugar, reduce cholesterol, improve blood pressure, and reduce inflammation.

• Monitor cardiovascular health: Beyond standard cholesterol tests, discuss advanced screenings with your doctor to fully understand your heart risks.

Looking Ahead: Treatments for Both Inflammation and Metabolic Health

In the coming years, expect to see more treatments that cross over between inflammation control and metabolic improvement. For example, GLP-1 agonists like semaglutide and tirzepatide—commonly prescribed for diabetes and weight loss—are showing promising effects on inflammation as well.

For clinicians and patients alike, this represents an exciting opportunity: therapies that target metabolic health may also reduce autoimmune-related inflammation, and vice versa.

Takeaway

The findings on methotrexate and blood pressure in RA patients highlight a crucial point: your joint health, immune health, and cardiovascular health are deeply connected. By treating inflammation effectively, you may also be protecting your heart.

In the meantime, the best things you can do are within your control:

• Eat an anti-inflammatory diet

• Stay physically active

• Manage your weight, blood sugar, cholesterol, and blood pressure

These lifestyle choices—combined with effective RA treatments—can help you live healthier with less inflammation and a lower risk of cardiovascular disease.